Cargando…

Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment

Detalles Bibliográficos
Autores principales:	Bruijstens, Arlette L, Blok, Katelijn M, Smolders, Joost, Wokke, Beatrijs HA, Neuteboom, Rinze F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720353/ https://www.ncbi.nlm.nih.gov/pubmed/32406801 http://dx.doi.org/10.1177/1352458520921367

Ejemplares similares

Disease activity in primary progressive multiple sclerosis: a systematic review and meta-analysis
por: Blok, Katelijn M., et al.
Publicado: (2023)

HLA association in MOG-IgG– and AQP4-IgG–related disorders of the CNS in the Dutch population
por: Bruijstens, Arlette L., et al.
Publicado: (2020)

Should anti-CD20 be used as an immune reconstitution therapy?
por: Smets, Ide, et al.
Publicado: (2022)

Health-economic benefits of anti-CD20 treatments in relapsing multiple sclerosis estimated using a treatment-sequence model
por: Smets, Ide, et al.
Publicado: (2023)

Naive B cells in neuromyelitis optica spectrum disorders: impact of steroid use and relapses
por: Janssen, Malou, et al.
Publicado: (2020)

Distinct Effector Programs of Brain-Homing CD8(+) T Cells in Multiple Sclerosis
por: Koetzier, Steven C., et al.
Publicado: (2022)

Brain-homing CD4(+) T cells display glucocorticoid-resistant features in MS
por: Koetzier, Steven C., et al.
Publicado: (2020)

Real-world validation of the 2017 McDonald criteria for pediatric MS
por: Wong, Yu Yi M., et al.
Publicado: (2018)

Neurodegeneration and humoral response proteins in cerebrospinal fluid associate with pediatric-onset multiple sclerosis and not monophasic demyelinating syndromes in childhood
por: Bruijstens, Arlette L, et al.
Publicado: (2022)

Raloxifene May Have Further Benefits in Women on Hemodialysis
por: Worsley, Roisin, et al.
Publicado: (2012)

YOGA MAY HAVE HEALTH BENEFITS FOR PEOPLE WITH ASTHMA
Publicado: (2016)

Implications of Lymphocyte Anergy to Glycolipids in Multiple Sclerosis (MS): iNKT Cells May Mediate the MS Infectious Trigger
por: Hogan, Edward L, et al.
Publicado: (2013)

Quantitative multiplex immunohistochemistry with colorimetric staining (QUIVER) may still benefit from MILAN
por: Bolognesi, Maddalena M., et al.
Publicado: (2023)

Regular Meeting, May 24, 1875
por: Sawyer, E. Warren
Publicado: (1875)

Both cladribine and alemtuzumab may effect MS via B-cell depletion
por: Baker, David, et al.
Publicado: (2017)

Pediatric autoimmune encephalitis: Recognition and diagnosis
por: de Bruijn, Marienke A.A.M., et al.
Publicado: (2020)

MERS may not be SARS; but India is still vulnerable
por: Kant, Lalit
Publicado: (2015)

Bacteria may be in the liver, but the jury is still out
por: Broderick, Nichole A., et al.
Publicado: (2022)

Erythropoietic Protoporphyria: You May Not Have Seen It, but It May Have Seen You
por: Pastore, Larissa M, et al.
Publicado: (2022)

FREE TRANSPORTATION SERVICE RECIPIENTS MAY HAVE BETTER QUALITY OF LIFE BUT STILL LACK IN IMPROVING HEALTH
por: Tomita, Machiko R
Publicado: (2019)

Clinical relevance of guanine-derived urinary biomarkers of oxidative stress, determined by LC-MS/MS
por: Shih, Ying-Ming, et al.
Publicado: (2018)

Metabolic Footprinting of Microbial Systems Based on Comprehensive In Silico Predictions of MS/MS Relevant Data
por: Reiter, Alexander, et al.
Publicado: (2022)

Aryl hydrocarbon receptor activity may serve as a surrogate marker for MS disease activity
por: Sabatino, Joseph J., et al.
Publicado: (2017)

Differences in common heritable blood immune cell populations may underlie MS susceptibility and progression
por: Booth, David R, et al.
Publicado: (2016)

Efficacy of Disease Modifying Therapies in Progressive MS and How Immune Senescence May Explain Their Failure
por: Manouchehri, Navid, et al.
Publicado: (2022)

Acute Resistance Training May Have Lasting Benefit to Middle-Aged Adults
por: Baker, Breanne S., et al.
Publicado: (2021)

Exercise during pregnancy may have more benefits than we thought
por: Wang, Lingdi, et al.
Publicado: (2022)

A framework for measurement and harmonization of pediatric multiple sclerosis etiologic research studies: The Pediatric MS Tool-Kit
por: Magalhaes, Sandra, et al.
Publicado: (2018)

Behavior of Regular Insulin in a Parenteral Nutrition Admixture: Validation of an LC/MS-MS Assay and the In Vitro Evaluation of Insulin Glycation
por: Henry, Heloise, et al.
Publicado: (2022)

Metabolomics Benefits from Orbitrap GC–MS—Comparison of Low- and High-Resolution GC–MS
por: Stettin, Daniel, et al.
Publicado: (2020)

Chicago Medical Society: Regular Meeting, May 21
Publicado: (1888)

Chicago Medical Society: Regular Meeting, May 7
Publicado: (1888)

Chicago Medical Society: Regular Meeting May 5
por: Park, Roswell, et al.
Publicado: (1879)

Determination of metformin bio-distribution by LC-MS/MS in mice treated with a clinically relevant paradigm
por: Chaudhari, Kiran, et al.
Publicado: (2020)

An Ultrasensitive Routine LC-MS/MS Method for Estradiol and Estrone in the Clinically Relevant Sub-Picomolar Range
por: Bertelsen, Bjørn-Erik, et al.
Publicado: (2020)

Identification of proteins in housefly (Musca domestica) larvae powder by LC-MS/MS and their potential medical relevance
por: Jiao, Mengya, et al.
Publicado: (2019)

Increased Within-Network Functional Connectivity May Predict NEDA Status in Fingolimod-Treated MS Patients
por: Piervincenzi, Claudia, et al.
Publicado: (2021)

Is CSF neurofilament light chain measurement relevant for MS?
por: Matsui, Makoto
Publicado: (2020)

Neurofilament Light Chain in Adult and Pediatric Multiple Sclerosis: A Promising Biomarker to Better Characterize Disease Activity and Personalize MS Treatment
por: Ghezzi, Angelo, et al.
Publicado: (2023)

DNase to the Rescue! Clearing Mitochondrial DNA May Have NET Benefits in Lung Transplantation
por: Juvet, Stephen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aoj0jc9cfk0bdbrmd981li7g2k